Further analysis showed that a co-dominant gene called SM2, located in the 6q22-q23 region, close to the interferon-gamma receptor 1 (IFNGR1) gene, which encodes the IFN-γ α chain receptor and controls disease progression by affecting fibrosis and portal hypertension [125,128]. This evidence concerns the gene IFNGR1 and liver disorder.